Fundraising Fox
Asieris
Founded 2010 · 60 employees on LinkedIn · 4 known investors
Find your way into Asieris
Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.
Investors · 4
EFung Capitallisted by EFung CapitalShenzhen
How we know: EFung Capital's portfolio page · Not right? Tell us
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing · $5M – $134M
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
TriWise CapitalreportedShenzhen
How we know: funding news · Not right? Tell us
YF CapitalreportedHong Kong
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Asieris do?
- Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.
- Who are Asieris's investors?
- Asieris's investors include EFung Capital, Qiming Venture Partners, TriWise Capital, YF Capital.